These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34446094)

  • 1. Quality of selected anti-retroviral medicines: Tanzania Mainland market as a case study.
    Mziray S; Maganda BA; Mwamwitwa K; Fimbo AM; Kisenge S; Sambu G; Mwalwisi YH; Bitegeko A; Alphonce E; Khea A; Shewiyo DH; Kaale E
    BMC Pharmacol Toxicol; 2021 Aug; 22(1):46. PubMed ID: 34446094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post marketing surveillance of selected veterinary medicines in Tanzania mainland.
    Fimbo AM; Maganda BA; Mwamwitwa KW; Mwanga IE; Mbekenga EB; Kisenge S; Mziray SA; Kulwa GS; Mwalwisi YH; Shewiyo DH
    BMC Vet Res; 2022 Jun; 18(1):216. PubMed ID: 35681204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy supply chain quality control and assurance in improving people living with HIV therapeutic outcomes in Cameroon.
    Djobet MP; Singhe D; Lohoue J; Kuaban C; Ngogang J; Tambo E
    AIDS Res Ther; 2017 Apr; 14(1):19. PubMed ID: 28376825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Assessment of Quality of Antimalarial Medicines in Mainland Tanzania: Insights from Five Years of Postmarket Surveillance.
    Mlugu EM; Mhagama J; Matiko D; Agustine S; Nandonde M; Masunga E; Kunambi PP; Sangeda RZ; Mwalwisi YH; Fimbo A
    Am J Trop Med Hyg; 2024 Dec; 111(6):1215-1222. PubMed ID: 39353417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of antiretroviral, antimalarial and antituberculosis medicines in Zambia: Findings of routine post-marketing surveillance.
    Jere E; Munkombwe D; Mukosha M; Mudenda S; Kalungia AC; Chabalenge B
    J Med Access; 2024; 8():27550834241266755. PubMed ID: 39071988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Quality of Selected Essential Medicines Sold in Accredited Drug Dispensing Outlets and Pharmacies in Tanzania.
    Kaale E; Manyanga V; Chambuso M; Liana J; Rutta E; Embrey M; Layloff T; Johnson K
    PLoS One; 2016; 11(11):e0165785. PubMed ID: 27846216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Presence of Falsified and Poor-Quality Fixed-Dose Combination Artemether-Lumefantrine Pharmaceutical Dosage Forms in Kumasi, Ghana.
    Nyarko S; Ofori-Kwakye K; Johnson R; Kuntworbe N; Yar DD
    Adv Pharmacol Pharm Sci; 2024; 2024():2650540. PubMed ID: 38562542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quality of antiretroviral medicines: an uncertain problem.
    Do NT; Boupha P; Newton PN; Caillet C
    BMJ Glob Health; 2023 Mar; 8(3):. PubMed ID: 36921990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The malaria testing and treatment landscape in mainland Tanzania, 2016.
    ; Michael D; Mkunde SP
    Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and Northeastern Democratic Republic of Congo.
    Schäfermann S; Hauk C; Wemakor E; Neci R; Mutombo G; Ngah Ndze E; Cletus T; Nyaah F; Pattinora M; Wistuba D; Helmle I; Häfele-Abah C; Gross H; Heide L
    Am J Trop Med Hyg; 2020 Aug; 103(2):894-908. PubMed ID: 32394884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?
    Dionisio D; Gass R; McDermott P; Racalbuto V; Madeo M; Braghieri G; Crowley S; Pinheiro Edos S; Graaff P; Vasan A; Eksaengsri A; Moller H; Khanna AK; Kraisintu K; Juneja S; Nicolaou S; Sengupta A; Esperti F; Messeri D
    Curr HIV Res; 2007 Mar; 5(2):155-87. PubMed ID: 17346132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral Therapy in the Real World : Population-Based Pharmacoeconomic Analysis of Administration of Anti-HIV Regimens to 990 Patients.
    Sabbatani S; Manfredi R; Biagetti C; Chiodo F
    Clin Drug Investig; 2005; 25(8):527-35. PubMed ID: 17532696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern Malawi.
    Khuluza F; Kigera S; Heide L
    Am J Trop Med Hyg; 2017 May; 96(5):1124-1135. PubMed ID: 28219993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T; Rao Thudi N; Koundinya Tippabhotla S; Khuroo A; Marwah A; Kumar Shrivastav V; Tandon M; Raghuvanshi R; Biswal S
    Clin Ther; 2007 Dec; 29(12):2677-84. PubMed ID: 18201583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
    Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
    PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-dose, randomized, open-label, two-period crossover bioequivalence study comparing a fixed-dose pediatric combination of lamivudine and stavudine tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T; Reyar S; Tiwari HK; Tippabhotla SK; Khuroo A; Thudi NR; Ahmed S; Raghuvanshi R
    Arzneimittelforschung; 2009; 59(2):104-8. PubMed ID: 19338141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.